Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


 

Compressus' Next Generation MEDxConnect(TM) Interoperability Solutions Feature GE Centricity and Philips iSite Integrations

Fri. November 21, 2008; Posted: 08:00 AM
Stocks RSS
WASHINGTON, Nov 21, 2008 /PRNewswire via COMTEX/ -- HOLX | Quote | Chart | News | PowerRating -- Interoperability pioneer Compressus, Inc. today introduced the next generation of its comprehensive suite of Enterprise Systems Integration software solutions with the release of the MEDxConnect(TM) System version 2.5. The new release features a full integration with GE Centricity PACS and significant enhancements to the Company's comprehensive interoperability solutions package that increase the efficiency and automation benefits that made the initial release successful. The first and only software solution that indexes, integrates and routes all relevant patient medical information in real time, increasing patient safety, improving physician productivity and supporting practice expansion, MEDxConnect enables organizations with disparate multi-vendor systems to function as one virtual enterprise.

Fully supporting a Thin Client environment, MEDxConnect version 2.5, offers full integration with GE Centricity PACS. Featuring a collaborative development and testing process, MEDxConnect is fully interoperable with GE Centricity PACS and Centricity IW. Compressus also recently completed new integrations with Philips iSite, Hologic SecurView, Visage Imaging, and PowerScribe speech recognition software, continuing to expand its industry leading portfolio of workstation, VR, RIS and PACS integrations. The ability to address all PACS viewing environments, assures customer confidence and ease of use while helping to maintain and leverage previous IT and infrastructure investments.

According to Mark Gonwa, MD, radiologist and president of E-Rad Solutions, a teleradiology service provider that uses MEDxConnect system to help imaging practices optimize workflow, the 2.5 release continues to improve access to critical patient information as referred to in a recent report in the Journal of Digital Imaging, which cites lack of access to pertinent clinical patient data may be a critical element that limits the accuracy of the radiologist's diagnostic decision-making process.

"The findings support our own experiences, that most radiologists want more clinical information when interpreting images and that this information would impact their report, but are discouraged by the time it takes to access this information. The researchers concluded that based on the fact that hospitals have multiple different systems used to access clinical data, which presents challenges through multiple logins and user interfaces, there is a critical need for an integrated application for the automatic identification, selection, retrieval and display of pertinent patient information at the time of interpretation. Since we implemented MEDxConnect for a hospital group in Florida, we have easy access to all data critical for us to make accurate and expedient diagnoses. The system routinely provides reading physician's clinical documentation, prior reports and images with the new study automatically with no manual intervention," added Dr. Gonwa.

The Addendum Enhancement feature builds on MEDxConnect's proven single Virtual Worklist solution that enables users to automatically pre-fetch all types of patient information, including historical and demographic data, prior reports and images, and physicians' notes from disparate information and imaging systems, irrespective of vendor, and distribute it to the appropriate physicians in real-time. In addition to pre-fetching the user-configured number and type of studies and patient information, the System now also provides a list of other data that is available should the physician want it to make their read. Users now have the option to permanently attach this new data to the original study packet, ensuring that it is available for referring physicians or future reads.

Other new features include the Order Management Module OM2 module, which automatically creates an electronic order in cases where there is no RIS. Needed for other systems in the Enterprise, such as VR, to acknowledge and process the exam packet, the OM2 now creates the order in HL7. The Study forward feature enables users to pass studies to specialists or colleagues for consultations. Previously, studies could not be forwarded or passed once they were claimed. Version 2.5 also expanded the ability for groups to customize routing and worklist rules through general, modality and subspecialty worklists. The enhanced ability to share studies, assures optimal sub-specialization and enhanced workflow.

"The study featured in the Journal of Digital Imaging continues to validate the reason we pioneered the concept of Interoperability System Solutions to the market in the first place; that the lack of interoperability between existing information and imaging systems is one of the most critical problems facing the diagnostic and management effectiveness of the healthcare profession today," said Janine Broda, vice president and general manager for Compressus' Medical Solutions Division. "With the next generation of the MEDxConnect System, we have expanded its capabilities to address all markets, from general imaging to subspecialty, and provide fast, effective, accurate, and affordable solution providing seamless connectivity and interoperability."

About MEDxConnect

The MEDxConnect System acts as a communications hub, enabling all PACS, HIS, RIS and other data information systems to connect and communicate across an enterprise. MEDxConnect also enhances and expedites the use of HL7, DICOM and other standard languages to connect flawlessly all of the otherwise independent and disparate systems and successfully transferring images, reports, messages, demographics and other important data for the timely diagnosis and treatment of a waiting patient. The integrated imaging and data management solution from Compressus is designed to support a facility's current and expanded workload and provide an infrastructure for sustained growth. Building the functionality required for remote connectivity, the system enables users to access diagnostic images and reports in the existing data stores at each facility, increasing the level of medical care while reducing the associated costs.

About Compressus, Inc.

Established in 2000, Compressus, Inc. is a medical software company offering proven solutions for problems of interoperability and interconnectivity in the rapidly growing healthcare IT market. Its MEDxConnect software is the first solution that indexes, integrates and routes all relevant patient medical information to the healthcare professional in real time, thus dramatically improving physician efficiency, reducing enterprise costs and increasing patient safety. The MEDxConnect products address the problems associated with integrating healthcare enterprises plagued by the lack of connectivity and interoperability between disparate vendors of HIS, RIS and PACS systems. Designed to manage the workflow of an imaging healthcare enterprise, the MEDxConnect System is a suite of offerings that has the power to connect disparate HIS/RIS/PACS systems and provide automated interoperability to the enterprise and allows an organization with disparate multi-vendor system function as one virtual enterprise.

SOURCE Compressus, Inc.

http://www.compressus.com

For full details on Hologic Inc (HOLX) click here. Hologic Inc (HOLX) has Short Term PowerRatings of 7. Details on Hologic Inc (HOLX) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.